Shreenivas A, Nishizaki D, Lee S, Pabla S, Nesline M, Conroy J
Int J Mol Sci. 2024; 25(9).
PMID: 38731962
PMC: 11083822.
DOI: 10.3390/ijms25094742.
Wang J, Ouyang X, Zhu W, Yi Q, Zhong J
Cancer Control. 2024; 31:10732748241241162.
PMID: 38533911
PMC: 10976495.
DOI: 10.1177/10732748241241162.
Kashfi S, Ghaedi K, Baharvand H, Nasr-Esfahani M, Javan M
Mol Neurobiol. 2016; 54(10):8128-8139.
PMID: 27889899
DOI: 10.1007/s12035-016-0292-6.
Singh A, Arya R, Trivedi A, Sanyal S, Baral R, Dormond O
Cytokine Growth Factor Rev. 2012; 24(1):41-9.
PMID: 22989616
PMC: 4172454.
DOI: 10.1016/j.cytogfr.2012.08.007.
Kavanagh D, Kalia N
Stem Cell Rev Rep. 2011; 7(3):672-82.
PMID: 21340505
DOI: 10.1007/s12015-011-9240-z.
CXCR4 and CXCR7 have distinct functions in regulating interneuron migration.
Wang Y, Li G, Stanco A, Long J, Crawford D, Potter G
Neuron. 2011; 69(1):61-76.
PMID: 21220099
PMC: 3025760.
DOI: 10.1016/j.neuron.2010.12.005.
The human A1 adenosine receptor: ligand binding properties, sites of somatic expression and chromosomal localization.
Rivkees S, Lasbury M, Stiles G, Henegariu O, Curtis C, Vance G
Endocrine. 2010; 3(9):623-9.
PMID: 21153220
DOI: 10.1007/BF02746338.
CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
de Oliveira K, Oda J, Voltarelli J, Nasser T, Ono M, Fujita T
J Clin Lab Anal. 2009; 23(6):387-93.
PMID: 19927352
PMC: 6649101.
DOI: 10.1002/jcla.20346.
Differential expression of RDC1/CXCR7 in the human placenta.
Tripathi V, Verma R, Dinda A, Malhotra N, Kaur J, Luthra K
J Clin Immunol. 2008; 29(3):379-86.
PMID: 18956235
DOI: 10.1007/s10875-008-9258-4.
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
Burns J, Summers B, Wang Y, Melikian A, Berahovich R, Miao Z
J Exp Med. 2006; 203(9):2201-13.
PMID: 16940167
PMC: 2118398.
DOI: 10.1084/jem.20052144.
Deletion of chromosome 2q37 and autism: a distinct subtype?.
Ghaziuddin M, Burmeister M
J Autism Dev Disord. 1999; 29(3):259-63.
PMID: 10425588
DOI: 10.1023/a:1023088207468.
RDCI, the vasoactive intestinal peptide receptor: a candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37.
Power M, James R, Barber J, Fisher A, Wood P, Leatherdale B
J Med Genet. 1997; 34(4):287-90.
PMID: 9138150
PMC: 1050913.
DOI: 10.1136/jmg.34.4.287.
Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.
Pauwels P, Palmier C, Wurch T, Colpaert F
Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(2):144-56.
PMID: 8717154
DOI: 10.1007/BF00168751.
Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.
Ferre S, Schwarcz R, Li X, Snaprud P, Ogren S, Fuxe K
Psychopharmacology (Berl). 1994; 116(3):279-84.
PMID: 7892417
DOI: 10.1007/BF02245329.
Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37.
Wilson L, Leverton K, Oude Luttikhuis M, Oley C, Flint J, Wolstenholme J
Am J Hum Genet. 1995; 56(2):400-7.
PMID: 7847374
PMC: 1801124.
Linkage refinement localises Sorsby fundus dystrophy between markers D22S275 and D22S278.
Gregory C, Wijesuriya S, Evans K, Jay M, Bird A, Bhattacharya S
J Med Genet. 1995; 32(3):240-1.
PMID: 7783180
PMC: 1050328.
DOI: 10.1136/jmg.32.3.240.
Receptor-receptor interactions as an integrative mechanism in nerve cells.
Zoli M, Agnati L, Hedlund P, Li X, Ferre S, Fuxe K
Mol Neurobiol. 1993; 7(3-4):293-334.
PMID: 7514001
DOI: 10.1007/BF02769180.